Statistics for Association BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer
Total visits
| views | |
|---|---|
| Association BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer | 3 |
Total visits per month
| views | |
|---|---|
| January 2024 | 1 |
| February 2024 | 0 |
| March 2024 | 2 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| Çeçener_vd_2018.pdf | 6 |